These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1908507)

  • 21. Vaccination with Leishmania mexicana LPG induces PD-1 in CD8⁺ and PD-L2 in macrophages thereby suppressing the immune response: a model to assess vaccine efficacy.
    Martínez Salazar MB; Delgado Domínguez J; Silva Estrada J; González Bonilla C; Becker I
    Vaccine; 2014 Mar; 32(11):1259-65. PubMed ID: 24462405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells by a model parasite antigen secreted into the parasitophorous vacuole or expressed on the amastigote surface.
    Wolfram M; Fuchs M; Wiese M; Stierhof YD; Overath P
    Eur J Immunol; 1996 Dec; 26(12):3153-62. PubMed ID: 8977317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells.
    Kima PE; Soong L; Chicharro C; Ruddle NH; McMahon-Pratt D
    Eur J Immunol; 1996 Dec; 26(12):3163-9. PubMed ID: 8977318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
    Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA
    J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
    Reiner NE
    J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced numbers of CD4+ suppressor cells with subsequent expansion of CD8+ protective T cells as an explanation for the paradoxical state of enhanced resistance to Leishmania in T-cell deficient BALB/c mice.
    Hill JO
    Immunology; 1991 Feb; 72(2):282-6. PubMed ID: 1826673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense.
    Sypek JP; Wyler DJ
    Infect Immun; 1990 May; 58(5):1146-52. PubMed ID: 2323812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes.
    Bogdan C; Stenger S; Röllinghoff M; Solbach W
    Eur J Immunol; 1991 Feb; 21(2):327-33. PubMed ID: 1900240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The scavenger receptor MARCO is involved in Leishmania major infection by CBA/J macrophages.
    Gomes IN; Palma LC; Campos GO; Lima JG; DE Almeida TF; DE Menezes JP; Ferreira CA; Santos RR; Buck GA; Manque PA; Ozaki LS; Probst CM; DE Freitas LA; Krieger MA; Veras PS
    Parasite Immunol; 2009 Apr; 31(4):188-98. PubMed ID: 19292770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge.
    Chávez-Fumagalli MA; Costa MA; Oliveira DM; Ramírez L; Costa LE; Duarte MC; Martins VT; Oliveira JS; Olortegi CC; Bonay P; Alonso C; Tavares CA; Soto M; Coelho EA
    Microbes Infect; 2010 Nov; 12(12-13):967-77. PubMed ID: 20601076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195.
    Guedes CES; Dias BRS; Petersen ALOA; Cruz KP; Almeida NJ; Andrade DR; Menezes JPB; Borges VM; Veras PST
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170345. PubMed ID: 29412342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells.
    Kima PE; Ruddle NH; McMahon-Pratt D
    J Immunol; 1997 Aug; 159(4):1828-34. PubMed ID: 9257846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction by specific T lymphocytes of intracellular destruction of Leishmania major in infected murine macrophages.
    Coutinho SG; Louis JA; Mauel J; Engers HD
    Parasite Immunol; 1984 Mar; 6(2):157-69. PubMed ID: 6609335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.
    Liew FY; Li Y; Millott S
    J Immunol; 1990 Dec; 145(12):4306-10. PubMed ID: 2175327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leishmania major infection in mice primes for specific major histocompatibility complex class I-restricted CD8+ cytotoxic T cell responses.
    da Conceição-Silva F; Perlaza BL; Louis JA; Romero P
    Eur J Immunol; 1994 Nov; 24(11):2813-7. PubMed ID: 7957573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.
    Liew FY; Millott S; Li Y; Lelchuk R; Chan WL; Ziltener H
    Eur J Immunol; 1989 Jul; 19(7):1227-32. PubMed ID: 2503386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model.
    Ali SA; Rezvan H; McArdle SE; Khodadadi A; Asteal FA; Rees RC
    Parasite Immunol; 2009 Jul; 31(7):373-83. PubMed ID: 19527453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis.
    Brodskyn CI; Barral A; Boaventura V; Carvalho E; Barral-Netto M
    J Immunol; 1997 Nov; 159(9):4467-73. PubMed ID: 9379046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity.
    Saha B; Das G; Vohra H; Ganguly NK; Mishra GC
    Eur J Immunol; 1995 Sep; 25(9):2492-8. PubMed ID: 7589116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.